Will worker DNELs derived under the European REACH regulation extend the landscape of occupational exposure guidance values?

  • Linda SchenkEmail author
  • Gunnar Johanson
Open Access
Review Article


Derived no-effect levels for workers (wDNELs) under the European REACH legislation have many aspects in common with occupational exposure limits (OELs). In an attempt to examine under which circumstances wDNELs might be used as exposure guidance outside their intended application, we compared derivation methods, coverage of substances and numerical values of wDNELs against two regulatory OEL lists (European Commission and Sweden) and three sets of recommendations (European SCOEL, German MAK and US ACGIH). Finally, we looked closer at wDNELs where SCOEL concluded that data were insufficient to derive an OEL. Major differences between wDNELs and OELs include regulatory background, intended use, actors involved, substance selection criteria, transparency and procedure of derivation, and operationalisation in terms of risk management measures. As of summer 2018, approximately five times more substances were covered by wDNELs than by the five sets of OELs examined herein. Meanwhile, many occupationally relevant pollutants were not covered by wDNELs, e.g. one-third of Swedish OELs lack corresponding wDNELs. We also note that wDNELs and OELs for the same substance may vary considerably, up to several orders of magnitude. In conclusion, with extensive substance coverage, wDNELs extend the landscape beyond the OELs. That said, important limitations are (1) that many air pollutants relevant for workers’ health are not covered by REACH, and (2) concerns for inconsistencies in the derivation of wDNELs and in their level of protection. In particular, that route-to-route extrapolation is a common practice that may be grossly misleading when the effect of concern is local, e.g. sensitisation.


Health risk assessment Industrial hygiene Maximum allowable concentration Route-to-route extrapolation Uncertainty factors TLV 


Chemicals in the workplace may be harmful to workers’ health and are consequently subject to various regulatory measures to prevent injury and disease. Within the EU, the so-called Framework Directive (Council 1989) lays out the basic occupational health and safety requirements. Under the Framework Directive, later directives more specifically targeting occupational exposure to chemicals have been adopted. Most significant of these are the Chemical Agents Directive (Council 1998) and the Carcinogens and Mutagens Directive (Council and Parliament 2004). Furthermore, a series of directives establishing lists of occupational exposure limits (OEL) have been adopted. The occupational health and safety directives do not apply directly to the member states’ workplaces, but have been transposed into national legislations.

The overall purpose of OELs is to protect workers’ health by stipulating a maximum allowable air-borne concentration of a chemical agent. OELs are a kind of performance standard; how these are to be achieved is not specifically stated, although there is a preference for adherence to a hierarchy of control measures (Council 1998), such as the STOP principle (Substitution, Technical controls, Organisational measures, Personal protective equipment). Moreover, the individual employer is operationally responsible, i.e. by implementation of measures resulting in exposures below the OELs.

The EU OELs should be transposed into the applicable legislation of the member states; however, many of the latter already have their own procedures in place for implementation of national OELs. Moreover, OELs are derived by several actors outside EU, and purposes, procedures, and sometimes also available scientific data-bases often differ. These discrepancies have lead to widely disparate values for the same chemical substance (Schenk 2010; Deveau et al. 2015).

An additional form of exposure guidance has been introduced through the European Chemicals regulation REACH (Registration, Evaluation, Authorisation and restriction of Chemicals, REACH Regulation 2006). The adoption of REACH was aimed to improve the protection of human health and the environment from potential hazards caused by chemicals. REACH, thus, targets chemicals broadly, including the protection of workers’ health. REACH stipulates that substances imported or manufactured in quantities above one tonne per annum (per manufacturer/importer) shall be registered. Furthermore, if the quantity exceeds ten tonnes, a chemical safety assessment shall be performed to demonstrate safe use of the chemical. The safety assessment includes derivation of so-called derived no-effect levels (DNELs). The DNELs shall be derived for all relevant populations, exposure durations and routes, including workers long-term inhalation exposure. The latter type of DNEL, hereafter called wDNEL, shows many similarities with OELs as both apply to the same population (workers), route (inhalation) and duration (long term).

While OELs are a performance standard and their implementation the responsibility of employer, the operational responsibility for adherence to wDNELs lies primarily on the manufacturers and importers of substances. That is, the instructions on safe use of a chemical product specified in (extended) safety data sheets should be developed in such a way that fulfilment of the instructions results in exposures below the wDNEL. In principle, these instructions should be sufficient for adherence to the wDNEL. Thus, there are important differences between wDNELs and OELs concerning the implementation and intended use within their respective regulatory framework (Table 1). Nevertheless, the similar forms (time-weighted averages of air-borne concentrations) and overall purpose (protection of workers’ health) made us wonder how the introduction of wDNELs has affected the broader landscape of OELs.
Table 1

Summary of major differences between derived no-effect levels for workers (wDNELs) derived by registrants and occupational exposure limits (OELs)




EU regulatory framework

REACH Regulation (2006)

OSH Framework Directive (Council 1989), Chemical Agents Directive (Council 1998) and Carcinogens and Mutagens Directive (Council and Parliament 2004), additional directives lying out safety measures and individual OELs

National regulatory framework

REACH applies directly

Directives are transposed into national OSH legislation


User instructions in (extended) Safety Data Sheet

Workplace specific risk management measures

Selection of substances

Tonnage imported/manufactured

Cause for concern is a universal selection criterion. Sometimes also practical considerations such as availability of data


Industry compiles scientific basis and performs the derivation (using ECHA guidance chapter R8)

Independent expert groups derive scientific basis and in some cases they derive a health-based OEL, in other cases the final OEL is set by the regulatory agency


ECHA guidance chapter R8, including a set of default AFs and instruction how to perform extrapolations

Methodologies of expert groups vary. Default AFs are generally not defined. For pragmatic OELs, socio-economic and practical considerations may be taken into account. Public consultation prior to finalisation is common

Accepted data

All available information, including confidential data

Published and peer-reviewed data generally preferred. Strictly confidential data may/may not be accepted

Influence of lack of data

Should lead to higher AFs. Qualitative hazard characterisation (e.g. “high hazard”) possible under certain circumstances

If scientific basis is poor, no OEL is derived

AF assessment factor, OEL occupational exposure limit, OSH occupational health and safety, wDNEL derived no effect level for workers longterm inhalation exposure.

Based on: Schenk (2010); Schenk and Johanson (2011); Schenk and Antonsson (2015); ACGIH (2017); DFG (2018); and SCOEL (2018)

The practical impact of wDNELs on the setting or application of OELs is as yet largely uninvestigated. However, various actors and regulatory actions suggest a growing and important role of wDNELs in the control of occupational exposure to chemicals. Deveau et al. (2015) explored a broad range of exposure guidance values applicable to the workplace and constructed a hierarchy with wDNELs placed between traditional OELs and hazard banding approaches. Schenk and Palmen (2013) investigated the motivations and purposes behind the introduction of a dual system of OELs in The Netherlands in 2005, a move that separated “private” OELs, to be derived by industry and intended to cover the majority of occupationally used substances, from “public” OELs (e.g. for chemicals “without owners”), which remained a task for government authorities. According to interviewed Dutch government officials, they had no intentions to equate such private OELs and wDNELs. Yet in practice, occupational hygienists seem to draw parallels between the two. For instance, 21% of occupational hygienists reported in a questionnaire that they applied the European Chemical Agency’s (ECHA) REACH guidance (ECHA 2012) when deriving private OELs (Schenk and Palmen 2013).

More importantly, the European Commission has indicated a desire to harmonise OELs and wDNELs. Thus, it requested its two relevant expert committees, the Scientific Expert Group on OELs (SCOEL) and the ECHA Risk Assessment Committee (RAC) to “(a) Develop and provide a joint opinion … on a recommendation for a limit value for worker protection for N-methylpyrrolidone (NMP) related to inhalation exposure and/or; (b) develop and provide an opinion on the recommendation for a limit value for worker protection for NMP related to inhalation exposure highlighting all issues, for which a common view between RAC and SCOEL could not be presented including methodology” (RAC and SCOEL 2016, p. 3). The two committees were further given the task to perform a comparative critical assessment of the DNEL and OEL methodologies with the aim “to improve mutual understanding of the different approaches and to work towards agreed common scientific approaches including through the further development of existing and new concepts as necessary in relation to workers’ exposure to chemicals” (RAC and SCOEL 2017, p. 5). The assessment revealed significant differences in the methodologies, and led the Commission to conclude “[g]iven the common function of such limit values in protecting workers, it is not considered practical or efficient to request both Committees to continue to work on the same chemical substances” (EC 2017a). The Commission furthermore decided to transfer SCOEL’s responsibilities to ECHA RAC (EC 2018; ECHA 2019).

While REACH registrants should derive DNELs and wDNELs by themselves, ECHA exerts a direct influence by providing the guidance (ECHA 2012) and RAC has a more indirect influence via publically available derivations for select chemicals under the restriction procedure and in terms of reference values for substances on the authorisation list.

Hence, wDNELs have many aspects in common with OELs, and may be expected to complement OELs in certain circumstances. Yet it is unclear which those circumstances should be. As a first step to illuminate this question, the present work targets similarities and differences through a detailed comparison of wDNELs and OELs, the latter exemplified by two sets of legislative OELs: the EU indicative OEL Values (IOELVs) and the Swedish OELs, and three sets of recommendations: the SCOEL recommendations, the German Maximum workplace concentrations (MAK values and) the Threshold Limit Values (TLVs) derived by the ACGIH. We review derivation methods and principles, the coverage of substances and compare the numerical values of the wDNELs and OELs, respectively. As data-poor substances may be an area where additional exposure guidance values are particularly useful, we specifically investigate wDNELs for substances for which SCOEL concluded that the data were insufficient for deriving an OEL.


The present study is based on a narrative literature review and comparisons of regulatory and recommended OELs (EC 1991, 2000, 2006, EC 2017b; ACGIH 2017; DFG 2018; SWEA 2018) to wDNELs collected from the ECHA database of registered substances. For counts of available wDNELs, we used the GESTIS compilation of wDNELs (, updated June 2018).

If more than one wDNEL was available, joint submissions and high tonnages were preferred over single submissions and low tonnages, respectively. If a registration dossier contained two wDNELs (i.e. one systemic and one local) the lower was chosen, as that one will determine the operational conditions and risk management measures implemented by the registrant and also those communicated down-stream through the safety data sheets. For metals and other substances where OEL setters made a joint assessment for a group of substances, we selected the elementary metal or, if not applicable, one registered substance among the examples listed by the OEL setters. For a number of substances ACGIH recommends exposures to be kept as low as possible, i.e. without any numerical TLV, this applied to two substances with wDNELs; these were excluded from the quantitative comparison of the exposure guidance levels.

Data-poor substances were identified by reading the OEL recommendation by SCOEL, available through the website of the European Commission (, 2019-03-18). All 192 documents published by SCOEL or its predecessor the Scientific Expert Group were read and searched for statements on data insufficiency regarding the derivation of 8-h time-weighted average (TWA) OELs. For each substance identified as lacking sufficient data, information on the effects of concern and kind of data identified as missing was extracted and tabulated (Supplemental material, Table S2).

Background information on wDNELs for selected substances was extracted from ECHA’s database of Registered Chemicals (

The focus of the present study lies on 8-h TWA OELs. Short-term exposure limits (STELs), ceiling limits (CLs) and acute wDNELs were not considered for two reasons. Firstly, STELs and CLs are generally described in less detail than TWAs in OEL documents. Secondly, comparisons with acute wDNELs are hampered by a large variation in time-frames for both types of short-term/acute values.

How are wDNEL derived?

As previously noted, wDNELs are derived not only by REACH registrants but also by the ECHA risk assessment committee (RAC). However, the by far largest proportion of wDNELs is derived by the registrants, which accordingly will be the focus in the coming sections. The differences between OELs and REACH wDNELs are summarised in Table 1. The selection procedure of substances to be considered differs considerably. Under the REACH Registration, the tonnage manufactured or imported triggers the need for information and chemical safety assessment, disregarding known hazards or data availability. In the work environment arena, on the other hand, a substance’s priority is usually driven by evidence or suspicion of adverse health effects and sometimes also practical factors such as availability of suitable toxicological data. Meanwhile, both wDNELs and OELs are based on an evaluation of the available scientific evidence and should indicate exposure levels that do not cause adverse health effects.

The actors and methodologies also differ between the two systems. OEL expert committees generally develop frameworks on how to set OELs. Further, they have systems to address conflicts of interest, to maintain stable work procedures and keep experts for several years. Moreover, most OEL setters have procedures for public consultation before finalising an OEL and the underlying documentation. All these procedures facilitate stability in the assessments. On the other hand, OEL committees generally have no predefined (default) uncertainty or AFs but tend to rely on case-by-case decisions (Dankovic et al. 2015). However, some describe principles guiding the choice of such factors (see, e.g. SCOEL 2018).

In contrast, the registrants (manufacturers or importers) that develop wDNELs constitute a disparate group, often dealing with one or a few chemicals only during a limited time period and all with a direct economic interest. To address these potential problems, ECHA offers extensive guidance on the prescribed steps towards a DNEL (ECHA 2012). The guidance includes advice on how to perform extrapolations as well as a set of default assessment factors (AFs) to cover certain aspects of variability and uncertainty, e.g. intra- and interspecies variability, duration of animal toxicity studies and data quality. The defaults should be applied unless deviations can be justified. Some qualitative, but no numerical, guidance is offered on when and how deviations from defaults are appropriate.

We have previously shown that the ECHA default AFs are higher than those explicitly or (mostly) implicitly applied by SCOEL (Schenk and Johanson 2010, 2011, 2018). The same goes for other OEL committees.

There is no public consultation of wDNELs, nor does ECHA systematically control all the submitted wDNELs, as the REACH regulation only requires ECHA to control at least 5% of all submitted registration dossiers [REACH Regulation 2006, Article 41(5)]. Lack of transparency is an issue for third party scrutiny of DNELs (Westerholm and Schenk 2014; Schenk et al. 2015; Ingre-Khans et al. 2016). The wDNELs and summaries of the data (exceptions for confidentiality are possible) they are based on are only partially publicly available through the registered substances database. The level of detail provided, such as which point of departure that was used, bibliometric references and AFs applied, varies considerably between substances (see also supplemental material). Additionally, a recent study comparing study summaries in 20 registrations with the original studies identified several issues with regards to the accuracy compared to the original (Ingre-Khans 2018).

In summary, while there are clear similarities in the overall aim and toxicological principles applied in the hazard assessment resulting in numerical values of the wDNELs and OELs, there are also many differences in their derivation processes. Major differences are the legislative demands, the selection of substances, the actor performing the scientific evaluation and the operationalisation. These differences lead us to expect a larger coverage of substances for wDNELs than OELs, due to the number of substances and their quantities on the European market and the fact that the safety assessment effort is divided over a much larger number of actors than OELs. However, they also give rise to some concern regarding the consistency in level of protection offered, as registrants are a much more diverse set of actors than OEL expert committees. These questions will be further explored in the coming sections.

How many substances have wDNELs?

Indeed, the number of wDNELs available is several times higher than the 100–800 substances found on national lists of OELs (Ding et al. 2011). Based on the GESTIS DNEL list, some 5200 unique EC numbers, and 3700 CAS numbers, are associated with one or several wDNELs. This can be compared to the 1406 CAS numbers covered by a compilation of OELs from ACGIH and 23 OEL setters across Asia and Europe (Ding et al. 2011). The European subset in this study covered 17 OEL lists and 1305 substances with CAS numbers (Ding et al. 2011).

We compared the coverage of four sets of OELs and wDNELs (Fig. 1). Notably, the coverages depend somewhat on how a substance is defined. For convenience, we chose to use the CAS numbers; however, nearly 30% of the wDNELs apply to substances without a CAS number (i.e. EC number only). This contrasts the finding by Ding et al. (2011) that 3–14% of the OELs in the investigated lists lacked a CAS number.
Fig. 1

Venn diagram comparing the number of individual substances (by CAS number) covered by wDNELs, EU IOELVs, the German MAK values, ACGIH TLVs, Swedish OELs (SE OEL). SCOEL recommendations were excluded as they overlap with EU IOELVs by nearly 100%. The areas are proportional to the number of substances

Regardless of how a substance is defined, the general picture remains the same. Thus, based on CAS numbers, there are 3.1 times more wDNELs than OELs (the four sets combined) whereas, counting chemical names, there are 5 times more wDNELs. Meanwhile, a substantial portion of the OELs cover substances without a wDNEL, ranging from 21% of the IOELVs to 57% of ACGIH TLVs (Fig. 1). Part of the selection criteria for an OEL is exposure relevance, i.e. for there to be a concern about a substance (and, accordingly, a need for an OEL), there has to be a use that may lead to occupational exposure. Overall, as a substantial part of the OELs do not have a corresponding wDNELs, we can conclude that wDNELs, although covering an unrivalled amount of substances, does not fully cover the range of workplace exposures in need of exposure guidance values.

The main reason for lack of a wDNEL is that the substance has not been registered (e.g. 50% of the IOELVs and 57% of the Swedish OELs lack a wDNEL, counting CAS numbers); other reasons are: use as intermediate only, low tonnage, qualitative hazard description only and exposure-based waiving. Substances of concern, regardless of tonnage are identified under the Evaluation, Restriction and Authorisation procedures. These procedures include prioritisation issues such as inclusion on the Candidate list of substances of very high concern. However, it is yet unclear how efficient the procedures are for managing chemical risks in the workplace.

To summarise, manyfold more substances have been attributed a wDNEL than an OEL. On the other hand, many substances that are not covered by wDNELs have been given an OEL, and are, thus, highly likely relevant for the work environment.

How do wDNEL values compare with OELs?

In total, 418 substances have both a wDNEL and at least one OEL from the investigated organisations. While many wDNEL and OEL values coincide or are very similar, some differ widely (Fig. 2). Among the 418 substances, 27 (6.5%) had a wDNEL that was more than 10 times higher than one or several OELs. About the double, 53 substances (13%) had a wDNEL that was more than 10 times lower than one or several OELs. In the extremes, the ratios span from 0.001 to 35,000, i.e. by seven orders of magnitude. There are, however, some variations between the different OEL setters, as seen in Fig. 2.
Fig. 2

Ratios between the numerical values of the wDNEL and the corresponding indicative OELs set by the European Commission (IOELV), the OELs recommended by the SCOEL (SCOEL REC), the German MAK and the US ACGIH TLV (ACGIH) committees, and the OELs set by the Swedish authority (SE OEL). Each dot represents a substance. Note the logarithmic X-axis

Prior to the first registration deadline, a substantial similarity was expected between EU IOELVs and wDNELs, as IOELVs were specifically mentioned as an acceptable alternative to derive wDNELs. This was also confirmed after the first (Nies et al. 2013) and second (Tynkkynen et al. 2015) registration deadlines, as the comparisons showed that three-quarters of the wDNELs were equal to the corresponding IOELVs. Tynkkynen et al. (2015) further noted that registrants also tended to adapt SCOEL recommendations not yet implemented as IOELVs.

The present study, covering wDNELs after the third registration deadline again shows that, on average, the wDNELs are quite similar to the EU IOELVs and the SCOEL recommendations (upper two clusters in Fig. 2), with 69% and 66%, respectively, of the ratios falling between 0.95 and 1.05. The geometric means of the ratios are 0.75 and 0.84, respectively, meaning that on average, the registrants’ wDNELs are slightly lower than the corresponding OELs. Looking at the extremes, the ratios range from 0.001 to 11.6 (i.e. the wDNELs may be from 1000 times lower to 11.6 times higher than the OELs, a discrepancy in the extremes of four orders of magnitude). Similarly, the wDNEL/SCOEL recommendation ratios range from 0.001 to 100, i.e. by five orders of magnitude. The somewhat higher discrepancy between wDNELs and SCOEL recommendations is due to SCOEL recommendations covering a slightly larger span of substances, not all have been promulgated as IOELVs. In addition, although not influencing the range of ratios, SCOEL has updated or retracted their recommendations for some substances.

Before and during the early phases of registrations under REACH, wDNELs were expected to turn out considerably lower than OELs besides the IOELVs, as a result of the default AF approach (Schenk and Johanson 2011; Kreider and Williams 2010). Yet, comparisons after the first and second registration deadlines have shown the two to be rather similar on average, although with a substantial spread (Nies et al. 2013; Schenk et al. 2015; Tynkkynen et al. 2015). Thus, wDNELs collected after the second registration deadline range from 230 times lower to 450 times higher than the Swedish OELs (Schenk et al. 2015) and from 2260 times lower to 7930 times higher than the Finnish OELs (Tynkkynen et al. 2015), by five and seven orders of magnitude, respectively, in the extremes.

The lower section of Fig. 1 shows the German MAK values, the ACGIH TLVs and the Swedish mandatory OELs as compared to wDNELs after the third registration deadline. All three sets of ratios show a larger variability than those for the EU IOELVs or SCOEL recommendations. Ratios between wDNEL and OEL were within the range of 0.95–1.05 in 34% of cases for MAK values, 18% of cases for ACGIH TLVs and 27% of cases for Swedish OELs. A comparison of the geometric means of the ratios establishes ACGIH TLVs (0.69) as slightly lower than the MAK (0.92) and Swedish OELs (0.75). The full range of ratios was 0.0018–437.5 for MAK (five orders of magnitude), 0.002–35,000 (seven orders) for ACGIH, and 0.001–875 for Swedish OELs (six orders).

Compared to Schenk et al. (2015), the number of substances with both a Swedish OEL and a wDNEL has increased by 28, due to new OELs as well as new registrations. Although the larger number or ratios has also led to a wider span between the extremes, there is also an indication of wDNELs being more aligned between registrants. In 2015, 17 substances with divergent wDNELs from different registrants were found (among substances having Swedish OELs); in the present study, this number was reduced to seven.

Lowering of the wDNEL (or OEL) does not necessarily result in a higher level of protection. In other words, a high wDNEL compared to the OEL (or vice versa) does not necessarily mean that the wDNEL is excessively high. For instance, higher exposure guidance may be motivated by new data, improved dose estimates, use of toxicokinetic and toxicodynamic models and/or refined mode of action reasoning. However, if the differences are significant in magnitude, it could indicate an insufficiently protective level. In the present study, we chose to investigate the cases where wDNELs are notably higher than one or several of the investigated OELs. Among the comparisons for the 418 substances in Fig. 2, 11 substances (2.6%) had at least one ratio exceeding a factor of 30 (listed in Table 2).
Table 2

Substances with one or several wDNEL/OEL ratios higher than 30


Ratio wDNEL/lowest OEL

wDNELa,b (mg/m3)

IOELV (mg/m3)

SCOEL REC (mg/m3)

MAK (mg/m3)

ACGIH TLVc (mg/m3)

Swedish OELc (mg/m3)

Trimellitic anhydride






Phthalic anhydride







Copper metal







Trichloroacetic acid






Sodium trichloroacetate




Gallium arsenide










Sodium metabisulphite




Maleic anhydride






Tin metal







White mineral oils






Not evaluated, Insuf data insufficient for recommending an 8-h TWA, I inhalable fraction; V Vapour; R respirable fraction; T total dust

aBackground information about wDNELs is shown the Supplementary material, Table S1

bAerosol and particle size is not specified for wDNELs

cFor particulates OELs refer to total particulate matter (ACGIH) total dust (SE OEL) unless otherwise specified

dThe wDNEL was submitted by a joint submission member, first presented conclusion of the joint submission is the qualitative “high hazard (no threshold derived)” and the most sensitive endpoint sensitisation

eCopper fume/copper dusts and mists

fExemplified by CAS 8042-47-5

Trimellitic anhydride, phthalic anhydride and maleic anhydride are respiratory sensitisers (e.g. ACGIH 2017), and the high values of the tabulated wDNELs (17.5, 32.2 and 0.4 mg/m3, respectively), in particular for the former two, are likely not protective of this effect. However, for trimellitic anhydride, the local wDNEL refers to “no-threshold effect and/or no dose–response information available” and the endpoint respiratory sensitisation. This may mean that the risk management measures communicated down-stream through the safety data sheet are not designed to meet the systemic wDNEL, but rather the qualitatively defined, and more severe, sensitisation hazard. This emphasises that numerical wDNELs should not be taken out of context of the full chemical safety assessment.

The wDNEL for copper metal of 1 mg/m3 is associated with the endpoint description “no hazard identified”. This is in sharp contrast with the SCOEL, who identified respiratory tract effects, including immunosuppression attributable to disturbed alveolar macrophage function as the critical effect (SCOEL 2014). It is further unclear whether the wDNEL applies to respirable, inhalable or total dust, although this would only explain a minor part of the difference in values.

The wDNELs for trichloroacetic acid (124.3 mg/m3) and sodium trichloroacetate (141 mg/m3) are both stated to be based on a repeated dose toxicity NOAEL, for local wDNELs it is stated “no-threshold effect and/or no dose–response information available” (no endpoint information given). For neither substance was there any inhalation study reported under repeated dose toxicity; thus, the wDNELs were presumably based on route-to-route extrapolation. Meanwhile, the two MAK values were based on irritation and analogy with phosphoric acid (Hartwig and MAK Commission 2016a).

The wDNEL of 0.02 mg/m3 for gallium arsenide was set for local effects; no other information was provided. The ACGIH TLV was based on pulmonary damage, noted amongst other species in rats starting from 0.01 mg/m3, the lowest dose tested in a 2-year inhalation study (documentation dated 2005 in ACGIH 2017).

The wDNEL of 0.64 mg/m3 for ziram was derived for systemic effects based on an oral study; however, it can be noted that the DNELfor workers’ short-term exposure and local effects, based on respiratory irritation, was set to the same level as the systemic wDNEL. The MAK value is based on respiratory effects seen in rodents after 28 days of exposure at 0.3 mg/m3, with no effects (NOAEC) at 0.1 mg/m3 (Hartwig and MAK Commission 2016b).

The wDNEL for sodium metabisulphite of 225 mg/m3 was derived for systemic effects, while for local effects it was stated “no-threshold effect and/or no dose–response information available”. No other information about the background was provided. The ACGIH TLV was established based on upper respiratory tract irritation by analogy with sodium bisulphite (documentation dated 2001 in ACGIH 2017).

The wDNEL for tin metal of 71 mg/m3 was based on a NOAEL from an oral study; no hazards were identified for local effects. The ACGIH TLV is intended to prevent stannosis (documentation dated 2001 in ACGIH 2017).

The wDNEL for white mineral oil of 160 mg/m3 (severely refined mineral oil, exemplified by CAS 8042-47-5) was derived for systemic effects, while no hazards were identified for local effects. No other information was provided. For severely refined mineral oils, SCOEL identified accumulation of oil-laden macrophages and the formation of granuloma as critical effects, noted in rats and dogs after long-term exposure to 100 mg/m3 (SCOEL 2011).

In summary, for a substantial number of substances, the wDNEL is excessively high compared to the OEL. This is mainly due to an inappropriate assumption of systemic toxicity as the leading effect (and, hence, application of route-to-route extrapolation) in the derivation of the wDNEL. Meanwhile, the OEL documentation shows that local effects such as respiratory sensitization and irritation are critical. Although qualitative hazard conclusions (on, e.g. sensitization) rather than the numerical wDNELs might form the basis for the risk management measures defined in the above cases, excessively high wDNELs values are severely misleading and may give employers and employees a false sense of safety.

Do wDNELs offer exposure guidance for data-poor substances?

In total, SCOEL deemed data insufficient for deriving an 8-h TWA OEL for 19 substances, or groups of substances (evaluated in 17 documents, Table 3). There are several forms of data insufficiency such as lack of data to identify the effect(s) of concern, lack of data to evaluate the relevance for occupational exposure, lack of data for the inhalation route and lack of adequate dose–response data. For more than half of these cases, the concern was lack of suitable and adequate dose–response data, e.g. data did not cover the relevant exposure range (no NOAEC or LOAEC identifiable), available studies lacked reliable exposure estimates and/or controlled experimental animal data were not available. Furthermore, carcinogenicity data was missing in several cases, in four cases SCOEL voiced concern for carcinogenicity but concluded that available data did not allow determination of human relevance (Table 3). In a few cases (lithium hydride and methyl isocyanate), SCOEL judged the data sufficient to propose a STEL value but not an 8-h TWA.
Table 3

Substances for which SCOEL judged data insufficient to propose an 8-h occupational exposure limit

Substancea, year and document

Effects of concern

Summary of described data (in)sufficiencyb



Sum 180



Scattered human data indicate irritation

No adequate inhalation studies available to assess the systemic toxicity



Sum 60

Systemic toxicity

Human data: poor exposure assessments and confounded by dermal exposure

No adequate inhalation studies in animals



Sum 96


Adequate inhalation studies are not available, no inhalation NOAEC

Carcinogenicity studies are not available



Sum 135

No reports of health effects in humans

No data on absorption of inhaled H4EDTA (human or animal)

No repeated dose inhalation animal experiments

Furfuryl alcohol


Sum 129



Very little human data

No inhalation NOAEC

Unclear mechanism for nasal and kidney tumours

No relevant published reproductive toxicity data

Lithium hydride


Sum 141


Data only sufficient for a STEL, experience from lithium therapy indicates systemic adverse effects are unlikely

Methyl iodide


Sum 80


Only limited toxicological data available

Studies available are not appropriate for evaluation of carcinogenicity potential

Methyl Isocyanate


Sum 118


Lung damage

No reliable studies on the relationship between occupational exposure and effects on health

Two studies on dose–response relationships for humans, but only a few minutes exposure

A STEL is proposed, longterm systemic effects are unlikely at this level even after prolonged exposure

Monochloroacetic acid


Sum 131


Effects after inhalation are not well established; threshold for irritation of the airways is not supported by available data



Sum 90

Haemolytic anaemia

Respiratory tract damage


No useful information is available on the dose–response relationship for hemolytic anaemia

No human data and no rodent NOAEC regarding respiratory tract damage

Insufficient clarity regarding the carcinogenic potential



Sum 103


No data in local effects after prolonged inhalation exposure

Only oral studies available, first-pass metabolism hampers route-to-route extrapolation

Lack of methods for sampling and measuring nonylphenol in air

Phthalic anhydride


Sum 152


Poor human data on dose–response, not possible to identify a NOAEC or a LOAEC

Not always possible to separate irritant and allergic respiratory effects

No NOAEC or LOAEC identifiable from animal experimental data

Picric acid


Sum 92


No data absorption of inhaled picric acid in humans or in animals

Lack of suitable human and animal repeated dose inhalation data

Weak genotoxic potential has been shown

Platinum metal and insoluble compounds


Sum 150

Not stated

Very few data are available regarding effects in humans

No animal data on sensitisation or eye irritation

No acute or repeated inhalation data

Data on carcinogenicity is lacking

Both negative and positive human lymphocyte micronucleus tests

Soluble platinum compounds


Sum 150


Too large gap between NOAECs and LOAECs in available human data

No data on carcinogenicity

Lack of in vivo genotoxicity data

Relevance of reproductive toxicity cannot be assessed due to exposure route differences



Sum 106


Liver and kidney toxicity

Not possible to identify with confidence a level of inhalation exposure that does not pose a concern of toxicity to the upper respiratory tract in humans

Tin metal


Sum 97


Human case reports with poor exposure assessment and old examination methods

Little evidence that occupational exposure to tin and tin dioxide pose any significant health risk

Inorganic tin compounds


Sum 97


Due to lack of data on tin salts other than SnCl2 and SnCl4, it cannot be excluded that soluble tin salts may cause irritation at lower air levels than resulting in systemic effects

Trichloroacetic acid


Sum 77


No reliable dose–response information for sensory irritation

Not possible to identify the critical effect for inhalation exposure

Only limited animal data available

EDTA ethylenediaminetetraacetic acid, NOAEC no observer adverse effect concentration, LOAEC lowest observed adverse effect concentration

aEach SCOEL recommendation has only been listed once, even if applied to several substances counting CAS numbers. OEL recommendation by SCOEL are available through the website of the European Commission ( (2018-12-18)

bExcerpts from the SCOEL conclusions/recommendations are presented in the Supplementary material, Table S2

Considering the knowledge gaps summarised in Table 3, we note that some may be addressed by fulfilling the standard information requirements under REACH. The information requirements depend on the annual quantity of the substance that is manufactured or imported into the EU (Annexes VI–X to the REACH Regulation 2006; see also Table 2 in ECHA 2016). In brief (excluding conditions and exceptions), the requirements are: 1 tonne or more—in vitro tests and acute oral toxicity, 10 tonnes or more—acute inhalation and dermal toxicity, subacute repeated dose toxicity and screening for reproductive toxicity, 100 tonnes or more—subacute and subchronic repeated dose toxicity, pre-natal developmental toxicity and an extended one-generation reproductive toxicity study, 1000 tonnes or more—chronic repeated dose toxicity, carcinogenicity and developmental toxicity. If no route is specified in the information requirements, the registrants generally are to test the most appropriate route considering the likely route of human exposure. Annex VIII of the REACH Regulation (2006) specifies that “[t]esting by the inhalation route is appropriate if:exposure of humans via inhalation is likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size”. Hence, for substances exceeding 100 tonnes per annum (per importer or manufacturer), controlled experimental studies could meet a commonly identified data gap, namely the lack of reliable dose–response data. Furthermore, Annex VIII states that “studies shall be proposed by the registrant or may be required by the Agency in accordance with Articles 40 or 41 in case of:/…/indications of an effect for which the available evidence is inadequate for toxicological and/or risk characterisation. In such cases it may also be more appropriate to perform specific toxicological studies that are designed to investigate these effects”. However, the extent to which REACH data will meet these knowledge gaps in practice is unknown. Additionally, human data are not a part of REACH information requirements, while these are a preferred source of data for OEL derivation (SCOEL 2018).

Concerns about the sufficiency of REACH minimal information requirements have been raised previously, in the context of classification of substances in general (Rudén and Hansson 2010) and specifically for classification as a mutagen and/or carcinogen (Woutersen et al. 2018).

Turning to the question of how the paucity of data is managed in the derivation of wDNELs under the REACH registration process, an overview of the wDNELs for the fully registered substances is presented in Table 4. Lack of data is apparently an issue not only for OEL setting but also for wDNEL derivation. For metallic platinum and hexachloroplatinic acid (exemplifying the two groups of platinum substances), the registrants even opted for qualitative hazard descriptions rather than a quantitative wDNEL. In addition, there are differences in access to data between the two arenas. For eleven wDNELs, registrants refer to study reports as the decisive data source. Study reports may indeed improve the scientific basis of data-poor substances; however, out of the 19 substances in Table 4, only for two, mixed cresol isomers and methyl iodide, study reports filled the data gaps identified by the SCOEL to some extent. Additionally, in most cases, such study reports are confidential and/or difficult to retrieve for an external examiner. For seven wDNELs, registrants used more recent key studies than did the SCOEL recommendation. Another approach seems to be higher AFs (as compared to general OEL practice), generally in conjunction with the use of route-to-route extrapolation or read across. For eight wDNELs, the provided AF or implicit safety margin (calculated as the inhalation POD divided by the wDNEL) exceeds a value of 20. While this is higher than the AFs generally applied by the SCOEL (the geometric mean is 4.3 for recommendations based on animal data, Schenk and Johanson 2018), they are not high in relation to ECHA’s default factors (ECHA 2012). The combined default factors by ECHA for an animal point of departure start at 12.5 (2.5 for intra species not covering allometric scaling and a factor of 5 for interspecies variation in the worker population) and may range up to 225 (including 6 for extrapolation from subacute to chronic study duration and 3 for LOAEL to NOAEL extrapolation). As previously noted, the default range does not include any numerical guidance on AFs for quality of database. Importantly, these default AFs are not validated for oral to inhalation extrapolation.
Table 4

Summary of background for wDNELs for the data-poor substancesa


Leading effect



Key study(ies)



Nasal lesions





Male thyroid weight; female serum luteinizing hormone


2007P; 1989SR; 1997SR


Cresol, mixed isomers






Body weight decrease



1987P; 1988O



CNS depression; body weight decrease



1987P; 1988SR



Increased mortality, clinical signs, liver and kidney toxicity



1987P; 1988SR



Local effects in larynx



2010SR; 2014SR


Furfuryl alcohol

Nasal lesions



Methyl iodide


2005SR; 2008SR

Monochloroacetic acid

Growth depression and reduced water consumption





National OEL (EU and USA)


Phthalic anhydride




Hexachloroplatinic acid




Platinum metal

No bioavailability




Reversible effects on liver weight




Tin metal

No effects noted




Tin dichloride (II)

No effects noted


1972SR; 1974SR; 1982R


Trichloroacetic acid

Effects on mortality, body weight, haematology, urine analysis, gross pathology and histopathology





NS not stated, RDT repeated dose toxicity, MSE most sensitive endpoint, Inhal inhalation, ISM implicit safety margin, O other publication, P publication, POD point of departure, R review, RA read across, RTR route-to-route extrapolation, SR study report

aAdditional details on the wDNELs are tabulated in the supplement (Table S3)

bISM is calculated as the inhalation POD divided by the wDNEL

In summary, wDNELs are available for all substances where the SCOEL judged data insufficient to propose an OEL (Supplemental material, Table S3). The data paucity is met in several ways, e.g. by the use of non-publicly available data (study reports) and acceptance of oral to inhalation extrapolation. As noted in the previous sections, we have concerns about the level of protection offered by some of the wDNELs. We conclude that use of a wDNEL in place of an OEL or other occupational exposure guidance value requires a case-by-case evaluation of the scientific basis and intended exposure conditions.


The wDNELs constitute a readily available source of exposure guidance values with extensive substance coverage. As such, the wDNELs extend the landscape beyond the OELs. However, there are some important limitations. First, a considerable number of air pollutants that are relevant to control from a workers’ health perspective are not covered by REACH. Thus, one-third of the entries in the Swedish list of OELs do not have a wDNEL. Second, due to the high number of REACH registrants, there are concerns for inconsistencies in the derivation of wDNELs and, therefore, in their level of protection. Indeed, already in our limited comparison against four sets of OELs, we identified some excessively high wDNELs. It is obviously difficult to estimate the total occurrence of excessive wDNELs for data-poor substances, but we note that route-to-route extrapolation is a common practice that may be grossly misleading when the effect of concern is local, such as sensitisation.

Neither wDNELs nor OELs are a stand-alone measure for control of risk, each kind of exposure guidance applies in a frame-work of other requirements regarding identification of risk and risk management measures. Consequently, the distance between wDNELs and OELs should be seen in the light of the different purposes of the two legislations. The wDNEL is not the end-product of the registrants’ chemical safety assessment, but one of the steps in the identification of conditions under which a chemical agent can be used safely, for which it is conceivable that, e.g. qualitative hazard assessments may be used in parallel to wDNELs. An OEL, on the other hand, is the end-product of the expert group’s hazard assessment, in the sense that the expert group will not have a further role in the identification of necessary risk management measures at the workplace. We do, however, see multiple trends pointing towards wDNELs being perceived as being of equal standing as OELs (e.g. Schenk and Palmen 2013; EC 2018). As the responsibilities of SCOEL have been reassigned to RAC (ECHA 2019), the distance between the OEL procedure and wDNEL procedure may be reduced, thereby also reducing the disparities between the future numerical values of wDNELs and OELs. Indeed, the Commission Director-General for DG Employment, Social Affairs and Inclusion did comment that “having one common source for scientific advice under REACH and the health and safety at work directives will ensure coherence and further transparency” (quoted in ECHA 2019). As the first requests for RAC to derive OELs attached the SCOEL methodology (SCOEL 2018), and specified that RAC should follow the SCOEL procedures (EC 2017a), we see a potential both for the OELs to be influenced by the wDNEL methodology (i.e. ECHA 2012) and vice versa. If RAC wDNELs become influenced by SCOEL methodology, the indirect guidance these wDNELs constitute may, in turn, affect the derivation procedure and level of registrants’ wDNELs.

The most interesting direction for further research wDNELs currently is for data-poor substances, such as investigating the extent to which route-to-route extrapolation and the AF approach may lead to reliability issues with wDNELs. Route-to-route extrapolation involves issues such as first-pass metabolism and systemic vs local effects which may render extrapolation attempts arbitrary. Therefore, the frequency of route-to-route extrapolation should be thoroughly investigated, in conjunction with an analysis of its applicability for the substances and effects of concern. Such an overview would also assist in guiding revisions of the applicable guidance, which currently gives detailed advice on the modification for absorption differences across routes but little advice regarding conditions under which route-to-route is inappropriate (ECHA 2012).

For data-poor substances in the present paper, route-to-route extrapolation in most cases coincided with application of, compared to general practice for OEL setting, larger AFs. While there are several proposed evidence-based AFs in the literature and risk assessment guidance documents, these are for limited aspects of uncertainty where there are data for the different states of knowledge (e.g. chronic and subchronic studies). There is a further need to evaluate how AFs should be applied to extremely poor databases as well as to explore how to apply probabilistic approaches instead. This work should be combined with an effort to outline criteria for minimal data for quantitative health-based exposure guidance values.

The lack of data outlined by the SCOEL examples herein seems largely unaddressed by the standard information requirements for Registration under REACH. Additional data requirements may be triggered by other REACH procedures, such as Authorisation; however, these procedures are slower than the registration procedure and, as the REACH regulation has only been in place for a few years, it is too early to systematically investigate the impact of the other procedures on work place risk management.



This work was funded by the AFA Insurance Foundation (Project no. 160032).

Compliance with ethical standards

Conflict of interest

Gunnar Johanson is a member of SCOEL. The authors declare no other conflicts of interest.

Supplementary material

204_2019_2439_MOESM1_ESM.docx (40 kb)
Supplementary material 1 (DOCX 39 kb)


  1. American Conference of Governmental Industrial Hygienists (ACGIH) (2017) TLVs and BEIs. ACGIH, Cincinnati. ISBN 978-1-607260-90-5Google Scholar
  2. Council (1989) Council Directive of 12 June 1989 on the introduction of measures to encourage improvements in the safety and health of workers at work (89/391/EEC). Off J L 183(29.6):1–8Google Scholar
  3. Council (1998) Council Directive 98/24/EC of 7 April 1998 on the protection of the health and safety of workers from the risks related to chemical agents at work (fourteenth individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC). Off J L 131(5):11–23Google Scholar
  4. Dankovic DA, Naumann BD, Maier A, Dourson ML, Levy LS (2015) The scientific basis of uncertainty factors used in setting occupational exposure limits. J Occup Environ Hyg 12(suppl 1):S55–S68. CrossRefGoogle Scholar
  5. Deutsche Forschungsgemeinschaft (DFG) (2018) List of MAK and BAT values 2018. Maximum concentrations and biological tolerance values at the workplace. Report 54. Wiley, Weinheim (ISBN: 978-3-527-81840-2) Google Scholar
  6. Deveau M, Chen C-P, Johanson G, Krewski D, Maier A, Niven KJ, Ripple S, Schulte P-A, Silk J, Urbanus JH et al (2015) The global landscape of occupational exposure limits—implementation of harmonization principles to guide limit selection. J Occup Environ Hyg 12(sup1):S127–S144. CrossRefGoogle Scholar
  7. Ding Q, Schenk L, Malkiewicz K, Hansson SO (2011) Occupational Exposure Limits in Europe and Asia—continued divergence or global harmonization? Regul Toxicol Pharmacol 61:296–309. CrossRefGoogle Scholar
  8. European Chemicals Agency (ECHA) (2012) Guidance on information requirements and chemical safety assessment Chapter R.8: Characterisation of dose [concentration]-response for human health. November 2012. Version 2.1. ECHA, HelsinkiGoogle Scholar
  9. European Chemicals Agency (ECHA) (2016) Guidance on registration. November 2016. Version 3.0. ECHA, HelsinkiGoogle Scholar
  10. European Chemicals Agency (ECHA) (2019) ECHA to provide recommendations for occupational exposure limits. ECHA/PR/19/02. Accessed 18 Mar 2019
  11. European Commission (EC) (1991) Commission Directive 91/322/EEC of 29 May 1991 on establishing indicative limit values by implementing Council Directive 80/1107/EEC on the protection of workers from the risks related to exposure to chemical, physical and biological agents at work. Off J L 177(5):22–24Google Scholar
  12. European Commission (EC) (2000) Commission Directive 2000/39/EC of 8 June 2000 establishing a first list of indicative occupational exposure limit values in implementation of Council Directive 98/24/EC on the protection of the health and safety of workers from the risks related to chemical agents at work (Text with EEA relevance). Off J L 142(16):47–50Google Scholar
  13. European Commission (EC) (2006) Commission Directive 2006/15/EC of 7 February 2006 establishing a second list of indicative occupational exposure limit values in implementation of Council Directive 98/24/EC and amending Directives 91/322/EEC and 2000/39/EC (Text with EEA relevance). Off J L 38(9):36–39Google Scholar
  14. European Commission (EC) (2017a) Note to the attention of mr Geert Dancet, executive director, European Chemicals Agency (ECHA) GL/ps ARES env.b.2(2017)1407647. Accessed 18 Mar 2019
  15. European Commission (EC) (2017b) Commission Directive (EU) 2017/164 of 31 January 2017 establishing a fourth list of indicative occupational exposure limit values pursuant to Council Directive 98/24/EC, and amending Commission Directives 91/322/EEC, 2000/39/EC and 2009/161/EU (Text with EEA relevance) C/2017/0396. Off J L 27(1):115–120Google Scholar
  16. European Commission (EC) (2018) Commission Staff Working Document accompanying the document Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee Commission General report on the operation of REACH and review of certain elements conclusions and actions Annex 6 {COM(2018) 116 Final}. Accessed 18 Mar 2019
  17. Hartwig A, MAK Commission (2016a) Trichloressigsäure und Natriumtrichloracetat [Trichloroacteic Acid and Sodium Trichloroacetate] In German. Wiley.
  18. Hartwig A, MAK Commission (2016b) Ziram. Wiley.
  19. Ingre-Khans E (2018) Transparency within REACH? Regulatory risk assessment of industrial chemicals. Doctoral Dissertation. Stockholms Universitet, Stockholm (ISBN: 9789177973935) Google Scholar
  20. Ingre-Khans E, Ågerstrand M, Beronius A, Ruden C (2016) Transparency of chemical risk assessment data under REACH. Environ Sci Proc Imp 18:1508–1518. CrossRefGoogle Scholar
  21. Kreider ML, Williams ES (2010) Interpreting REACH guidance in the determination of the derived no effect level (DNEL). Regul Toxicol Pharmacol 58(2):323–329. CrossRefGoogle Scholar
  22. Nies E, Musanke U, Püringer J, Rühl R, Arnine M (2013) DNELs for workplaces—observations from an inspection of the DGUV DNEL list. Gefahrstoffe Reinhaltund der Luft 73(11/12):455–462Google Scholar
  23. Parliament and Council (2004) Directive 2004/37/EC of the European Parliament and of the Council of 29 April 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work. Off J L 229(29):23–34Google Scholar
  24. RAC and SCOEL (2016) ECHA Committee for Risk Assessment (RAC) and Scientific Committee on Occupational Exposure Limits (SCOEL) Joint Opinion to resolve differences in scientific opinion as regards exposure levels for N-methyl-2-pyrrolidone. Accessed 18 Mar 2019
  25. RAC and SCOEL (2017) Joint Task Force ECHA Committee for Risk Assessment (RAC) and Scientific Committee on Occupational Exposure Limits (SCOEL) on scientific aspects and methodologies related to the exposure of chemicals at the workplace. Accessed 18 Mar 2019
  26. REACH Regulation (2006) Regulation (EC) no 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). Off J L 396(30):1Google Scholar
  27. Rudén C, Hansson SO (2010) Registration, Evaluation, and Authorization of Chemicals (REACH) is but the first step—how far will it take us? Six further steps to improve the European Chemicals Legislation. Environ Health Perspect 118(1):6–10. CrossRefGoogle Scholar
  28. Schenk L (2010) Comparison of data used for setting occupational exposure limits. Int J Occup Environ Health 16:249–262. CrossRefGoogle Scholar
  29. Schenk L, Antonsson A-B (2015) Implementation of the chemicals regulation REACH—exploring the impact on occupational health and safety management among Swedish downstream users. Saf Sci 80:233–242. CrossRefGoogle Scholar
  30. Schenk L, Johanson G (2010) Use of uncertainty factors by the SCOEL in their derivation of health-based occupational exposure limits. Crit Rev Toxicol 40:791–798. CrossRefGoogle Scholar
  31. Schenk L, Johanson G (2011) A quantitative comparison of the safety margins in the European indicative occupational exposure limits and the derived no-effect levels for workers under REACH. Toxicol Sci 121:408–416. CrossRefGoogle Scholar
  32. Schenk L, Johanson G (2018) Use on uncertainty factors by the European Commission Scientific Committee of Occupational Exposure Limits: a follow up. Crit Rev Toxicol 48(7):513–521. CrossRefGoogle Scholar
  33. Schenk L, Palmen NGM (2013) Throwing the baby out with the bath water? Occupational hygienists’ views on the revised Dutch system for Occupational Exposure Limits. Ann Occup Hyg 57(5):581–592. Google Scholar
  34. Schenk L, Deng U, Johanson G (2015) Derived no-effect levels (DNELs) under the European chemicals regulation REACH—an analysis of long-term inhalation worker-DNELs presented by industry. Ann Occup Hyg 59(4):416–438. Google Scholar
  35. Scientific Committee on Occupational Exposure Limits (SCOEL) (2011) Recommendation from the Scientific Committee on Occupational Exposure Limits for Aerosols of Severely Refined Mineral Oils. SUM 163. Employment, Social Affairs and Inclusion; European CommissionGoogle Scholar
  36. Scientific Committee on Occupational Exposure Limits (SCOEL) (2014) Recommendation from the Scientific Committee on Occupational Exposure Limits for Copper and its inorganic compounds. SUM 171. Employment, Social Affairs and Inclusion; European CommissionGoogle Scholar
  37. Scientific Committee on Occupational Exposure Limits (SCOEL) (2018) Methodology for derivation of occupational exposure limits of chemical agents. The general Decision-Making Framework of the Scientific Committee on Occupational Exposure Limits (SCOEL) 2017. Employment, Social Affairs and Inclusion; European CommissionGoogle Scholar
  38. Swedish Work Environment Authority (SWEA) (2018) Hygieniska gränsvärden [Occupational Exposure Limits] AFS 2018:1. Swedish Work Environment Authority, Stockholm. ISBN 978-91-7930-649-6Google Scholar
  39. Tynkkynen S, Santonen T, Stockmann-Juvala H (2015) A comparison of REACH-derived no-effect levels for workers with EU indicative occupational exposure limit values and national limit values in Finland. Ann Occup Hyg 59(4):401–415. Google Scholar
  40. Westerholm E, Schenk L (2014) Comparative analysis of dermal exposure evaluations performed under different EU regulatory frameworks. Regul Toxicol Pharmacol 68:51–58. CrossRefGoogle Scholar
  41. Woutersen M, Beekman M, Pronk MEJ, Muller A, Joop A, de Knecht JA, Hakkert BC (2018) Does REACH provide sufficient information to regulate mutagenic and carcinogenic substances? Hum Ecol Risk Assess 1:4. Google Scholar

Copyright information

© The Author(s) 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  1. 1.Integrative Toxicology, Institute of Environmental MedicineKarolinska InstitutetStockholmSweden
  2. 2.Department of Philosophy and HistoryRoyal Institute of TechnologyStockholmSweden

Personalised recommendations